Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963K Sell
1,774
-16
-0.9% -$8.22K ﹤0.01% 2029
2026
Q1
$777K Sell
1,790
-6
-0.3% -$2.64K ﹤0.01% 2004
2025
Q4
$590K Buy
1,796
+179
+11% +$57.5K ﹤0.01% 2000
2025
Q3
$517K Buy
1,617
+73
+5% +$20.2K ﹤0.01% 1949
2025
Q2
$425K Sell
1,544
-3
-0.2% -$610 ﹤0.01% 1953
2025
Q1
$285K Sell
1,547
-49
-3% -$11.3K ﹤0.01% 2047
2024
Q4
$316K Hold
1,596
﹤0.01% 2008
2024
Q3
$333K Buy
1,596
+142
+10% +$30.3K ﹤0.01% 1991
2024
Q2
$341K Sell
1,454
-148
-9% -$29.3K ﹤0.01% 1751
2024
Q1
$284K Buy
1,602
+142
+10% +$22.4K ﹤0.01% 1900
2023
Q4
$201K Buy
+1,460
New +$169K ﹤0.01% 1725
2022
Q1
Sell
-1,731
Closed -$254K 1057
2021
Q4
$254K Buy
+1,731
New +$209K ﹤0.01% 843

Other funds holding NVMI

Cerity Partners's NVMI Position: Q2 2026 in Review

Cerity Partners reduced its Nova (NVMI) stake by 0.89% in Q2 2026, selling an estimated $8.22K and leaving 1,774 shares worth $963K. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

Cerity Partners first reported a position in NVMI in Q4 2021 and has held it in 12 quarters since. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Cerity Partners held 1,774 shares of Nova worth $963K as of Q2 2026.
  • Cerity Partners sold 16 Nova shares in Q2 2026, an estimated $8.22K.
  • Nova made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2029 holding.
  • Cerity Partners first reported a position in Nova in Q4 2021 and has held it in 12 quarters since.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.